Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AVY | 35.16% | $13.88B | -21.27% | 1.99% |
REGN | 35.11% | $69.68B | -33.78% | 0.00% |
SW | 34.39% | $23.23B | -3.70% | 2.36% |
CSGP | 34.31% | $33.45B | -17.90% | 0.00% |
TECH | 34.12% | $9.28B | -16.56% | 0.55% |
CTAS | 34.12% | $82.01B | +18.32% | 1.80% |
KRYS | 34.07% | $5.30B | +3.37% | 0.00% |
NTST | 32.52% | $1.29B | -13.77% | 5.26% |
NMAI | 31.80% | - | - | 14.02% |
ESS | 31.72% | $19.68B | +24.99% | 2.43% |
PSA | 31.64% | $51.64B | +1.49% | 4.05% |
AVB | 31.57% | $30.38B | +15.10% | 2.41% |
PFE | 31.32% | $142.98B | -9.15% | 6.81% |
AMGN | 31.13% | $164.90B | +7.96% | 2.98% |
VSH | 30.80% | $2.19B | -28.66% | 2.50% |
RGNX | 30.79% | $392.17M | -62.84% | 0.00% |
MCO | 30.75% | $83.00B | +17.39% | 0.76% |
ORC | 30.67% | $714.63M | -14.22% | 17.91% |
POWI | 30.44% | $2.90B | -28.75% | 1.62% |
AXTA | 30.21% | $7.17B | -4.45% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CXSE | -0.05% | $433.82M | 0.32% |
DBC | 0.27% | $1.33B | 0.87% |
CQQQ | 0.28% | $1.12B | 0.65% |
XHLF | -0.32% | $1.06B | 0.03% |
SGOV | 0.40% | $39.32B | 0.09% |
GXC | 0.49% | $478.20M | 0.59% |
FLCH | 0.71% | $177.61M | 0.19% |
XBIL | 0.72% | $711.70M | 0.15% |
TFLO | 0.80% | $6.75B | 0.15% |
PDBC | -0.83% | $4.83B | 0.59% |
UGA | -0.85% | $88.53M | 0.97% |
TBLL | -0.91% | $2.07B | 0.08% |
TBIL | 0.92% | $5.33B | 0.15% |
URNM | 1.02% | $1.25B | 0.75% |
KCCA | -1.13% | $108.82M | 0.87% |
CHIQ | 1.38% | $260.60M | 0.65% |
BOXX | -1.52% | $5.71B | 0.1949% |
COMT | -1.69% | $671.98M | 0.48% |
FTGC | 1.70% | $2.51B | 1.02% |
MCHI | 1.73% | $6.46B | 0.59% |
Yahoo
Studies on NTLA's gene-edited therapy, nex-z, are progressing well while other pipelines are picking up pace. Stiff competition in the target market is a woe.
Yahoo
We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other stocks that Jim Cramer looked at recently. Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on […]
Yahoo
Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.
SeekingAlpha
The PGIM Jennison Global Opportunities Fund returned -0.6%, holding up slightly better than the MSCI ACWI Index. Click here to read the full commentary.
Finnhub
POLITICAL ENGAGEMENT PRINCIPLES Our Mission Every day, Vertexians work hard to improve the lives of patients. In so doing, we recognize the importance of...
SeekingAlpha
PGIM Jennison Focused Growth Fund Q4 2024 Commentary
Double maintains 16 strategies that include VRTX - Vertex Pharmaceuticals, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 55.34% | $371.52M | 0.35% |
IBB | 52.49% | $5.96B | 0.45% |
VHT | 46.75% | $16.46B | 0.09% |
FBT | 46.10% | $1.09B | 0.56% |
FHLC | 45.97% | $2.70B | 0.084% |
XLV | 45.89% | $38.29B | 0.09% |
IYH | 45.88% | $3.19B | 0.39% |
IXJ | 45.80% | $3.94B | 0.41% |
FXH | 41.36% | $969.80M | 0.62% |
RSPH | 41.13% | $796.40M | 0.4% |
XBI | 41.07% | $5.45B | 0.35% |
PBE | 40.80% | $235.57M | 0.58% |
YYY | 39.23% | $550.05M | 4.6% |
IHE | 38.51% | $605.75M | 0.39% |
FDLO | 38.42% | $1.35B | 0.16% |
PPH | 38.36% | $672.53M | 0.36% |
RSPA | 38.23% | $293.87M | 0% |
USMV | 37.63% | $23.93B | 0.15% |
INCM | 37.26% | $557.11M | 0.38% |
CPRJ | 36.93% | $48.81M | 0.69% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -31.64% | $195.31M | 0.85% |
USDU | -14.43% | $213.62M | 0.5% |
BTAL | -13.60% | $393.05M | 1.43% |
TAIL | -12.45% | $84.36M | 0.59% |
UUP | -11.91% | $328.64M | 0.77% |
UNG | -7.29% | $413.30M | 1.06% |
BILS | -6.12% | $3.65B | 0.1356% |
KMLM | -5.48% | $222.39M | 0.9% |
CNYA | -5.33% | $221.36M | 0.6% |
ASHR | -5.24% | $2.66B | 0.65% |
DBE | -5.18% | $54.74M | 0.77% |
TPMN | -4.88% | $33.38M | 0.65% |
OILK | -4.69% | $67.10M | 0.69% |
USL | -4.68% | $47.09M | 0.85% |
BNO | -4.58% | $96.15M | 1% |
EQLS | -4.55% | $4.74M | 1% |
USO | -3.99% | $947.20M | 0.6% |
DBO | -3.69% | $199.76M | 0.77% |
KRBN | -3.49% | $172.54M | 0.85% |
KBA | -3.26% | $208.91M | 0.56% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CLLS | -<0.01% | $91.56M | -52.08% | 0.00% |
WST | 0.04% | $16.06B | -43.85% | 0.37% |
TDS | -0.05% | $4.39B | +140.45% | 0.42% |
AMPY | 0.06% | $156.90M | -41.15% | 0.00% |
TCMD | -0.07% | $306.61M | -20.00% | 0.00% |
UEC | -0.08% | $2.13B | -26.37% | 0.00% |
GDOT | 0.09% | $453.36M | -10.40% | 0.00% |
LQDT | -0.11% | $974.32M | +68.76% | 0.00% |
VRT | 0.12% | $28.27B | -9.09% | 0.18% |
GSAT | -0.12% | $2.69B | -3.49% | 0.00% |
PTEN | 0.13% | $3.16B | -31.41% | 3.93% |
BFAM | -0.15% | $7.26B | +11.68% | 0.00% |
FAT | -0.15% | $50.53M | -32.93% | 14.73% |
NIO | 0.18% | $7.21B | -16.67% | 0.00% |
LGF.A | 0.21% | $2.07B | -13.47% | 0.00% |
CCJ | -0.21% | $18.21B | -3.44% | 0.28% |
BRBR | -0.24% | $9.52B | +25.66% | 0.00% |
ALGT | 0.24% | $975.96M | -29.24% | 1.16% |
PULM | 0.27% | $26.26M | +310.86% | 0.00% |
FUBO | -0.27% | $990.28M | +83.54% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CPSH | -15.96% | $23.24M | -13.51% | 0.00% |
MESO | -14.62% | $1.54B | +141.72% | 0.00% |
MQ | -14.11% | $2.11B | -29.70% | 0.00% |
MNOV | -13.36% | $71.12M | 0.00% | 0.00% |
BYRN | -11.31% | $386.13M | +22.40% | 0.00% |
FATBB | -10.63% | $50.71M | -28.40% | 14.74% |
QNRX | -9.40% | $2.16M | -74.55% | 0.00% |
STG | -8.94% | $28.35M | -43.93% | 0.00% |
CLX | -8.20% | $18.02B | -4.46% | 3.31% |
LI | -7.93% | $21.04B | -15.72% | 0.00% |
CNK | -7.52% | $3.04B | +38.23% | 0.33% |
BTCT | -7.49% | $20.00M | +13.71% | 0.00% |
VSTA | -7.32% | $349.55M | +8.19% | 0.00% |
OMER | -7.11% | $490.83M | +145.51% | 0.00% |
ATUS | -6.53% | $1.28B | +6.13% | 0.00% |
APT | -6.32% | $54.58M | -19.55% | 0.00% |
CVM | -6.30% | $20.08M | -87.50% | 0.00% |
CMTL | -6.23% | $50.48M | -49.85% | 0.00% |
SEG | -6.18% | $264.34M | -19.16% | 0.00% |
ANF | -5.99% | $3.86B | -38.91% | 0.00% |
Current Value
$504.791 Year Return
Current Value
$504.791 Year Return